Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Population Health

Climate change is a public health emergency. Healthcare organizations have a moral imperative to work together and create a healthier environment for their communities.

President and CEO, Providence

Merck executives share their strategy for embedding health equity across the pharma value chain.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate Vice President for Health Equity and Lead, Merck for Mothers
Former Executive Director of Health Equity, Merck

Plus, Why We Should Still Be Thinking About Cumulative Population Immunity

Three takeaways from our analysis on possible Herd Immunity Threshold and how to reach it together.

Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Q&A with Esther Dyson

Non-profit Wellville helps communities build sustainable institutions and systems for the health and resilience of all their residents.

Partner and Chief Marketing Officer, Oliver Wyman

The distribution of COVID-19 vaccines like Moderna, Pfizer, and others demands immediate supply chain analysis and preparation.

Partner, Oliver Wyman
Partner, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

New Oliver Wyman analysis on when and how a vaccine may be available and key considerations for how to reach herd immunity.

CEO, Independent Grocers Alliance
Partner, Health and Life Sciences, Oliver Wyman

An Executive Q&A About an Industry With and Without Barriers

With consumer interest in virtual care booming, someone's home is often a sacred space that reveals contextual health details.

CFO, Mount Sinai Health System
Global Head, Provider, Health and Life Sciences, Oliver Wyman

Six strategies to optimize care while protecting those on the front lines of battling COVID-19.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Some of the best COVID-19 solutions to support Special Populations require unconventional methods.

Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Strategies and tactics to help hospitals and health systems prepare their operations and clinical teams for a fast-evolving emergency situation.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe